Back
DoorDash, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
80
DASH
DoorDash, Inc.
Last Price:
$228.10
Seasonality Move:
4.7%
Buy
67
KYMR
Kymera Therapeutics, Inc.
Last Price:
$78.09
Seasonality Move:
-9.68%
Buy
80
DoorDash, Inc. (DASH)
is a Buy
Is DoorDash, Inc. a Buy, Sell or Hold?
-
The current DoorDash, Inc. [DASH] share price is $228.13. The Score for DASH is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
DASH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $80.35. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DASH Stock Price Chart
What is DoorDash, Inc.'s stock price today?
-
The DoorDash, Inc. share price today is $228.13The current trend is moderately bullish and DASH is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $80.35The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
DASH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.27 | Buy |
| Relative Strength Index (14 RSI): | 52.25 | Buy |
| Chaikin Money Flow: | -2358797 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.03 | Buy |
| Relative Strength Index (14 RSI): | 54.68 | Buy |
| Chaikin Money Flow: | -224422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DASH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 232.24 | Sell |
| 20-day SMA: | 227.38 | Buy |
| 50-day SMA: | 224.98 | Buy |
| 200-day SMA: | 226.87 | Buy |
| 8-day EMA: | 230.43 | Sell |
| 20-day EMA: | 226.58 | Buy |
| 50-day EMA: | 225.44 | Buy |
| 200-day EMA: | 157.63 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.3 | Sell |
| 20-day SMA: | 80.34 | Buy |
| 50-day SMA: | 69.42 | Buy |
| 200-day SMA: | 47.86 | Buy |
| 8-day EMA: | 82.24 | Sell |
| 20-day EMA: | 79.61 | Buy |
| 50-day EMA: | 71.43 | Buy |
| 200-day EMA: | 53.99 | Buy |
DoorDash, Inc. Earnings Growth & DASH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $2.08 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.36 per share.
DoorDash, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||